China Universal Asset Management Company’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9K | Buy |
|
|||||
|
2025
Q1 | $50.7K | Sell |
|
|||||
|
2024
Q4 | $60K | Buy |
|
|||||
|
2024
Q3 | $54.4K | Buy |
|
|||||
|
2024
Q2 | $32.7K | Sell |
|
|||||
|
2024
Q1 | $65.4K | Buy |
|
|||||
|
2023
Q4 | $29.4K | Buy |
|
|||||
|
2023
Q3 | $6.42K | Buy |
|
|||||
|
2023
Q2 | $4.09K | Sell |
|
|||||
|
2023
Q1 | $3.78K | Buy |
|
|||||
|
2022
Q4 | $4.07K | Buy |
|
|||||
|
2022
Q3 | $4K | Buy |
|